Literature DB >> 33531673

Altered erythropoiesis in newborns with congenital heart disease.

Stephanie Y Tseng1, Zhiqian Gao1, Theodosia A Kalfa2,3, Nicholas J Ollberding3,4, Sammy Tabbah5, Regina Keller1, James F Cnota6,7.   

Abstract

BACKGROUND: Fetal hypoxia has been implicated in fetal growth restriction in congenital heart disease (CHD) and leads to stress erythropoiesis in utero. The objective is to assess erythropoiesis and its association with growth in newborns with CHD.
METHODS: Fetuses with prenatally diagnosed CHD from 2013 to 2018 were retrospectively reviewed. Pregnancies with multiple gestation, genetic abnormalities, major extra-cardiac anomalies, and placental abruption were excluded. Complete blood count tests at birth were compared to published normative values. Spearman correlation assessed associations of red blood cell (RBC) indices with birth anthropometrics and prenatal Doppler measures.
RESULTS: A total of 160 newborns were included. Median gestational age was 38.3 (37.3, 39.0) weeks. Infants ≥37 weeks gestation had lower hemoglobin (Hgb), hematocrit, and elevated nucleated RBC (nRBC), mean corpuscular volume, and mean corpuscular hemoglobin compared to reference. No differences in RBC indices were observed in infants <34 and 34-37 weeks gestation. There was no difference in Hgb and nRBC between CHD subgroups. Neither Hgb nor nRBC were associated with birth anthropometrics or Doppler patterns.
CONCLUSIONS: Term infants with CHD demonstrated multiple alterations in erythrocyte indices suggesting ineffective stress erythropoiesis in late gestation resulting in lower Hgb at birth. Altered erythropoiesis was not correlated to growth or Doppler patterns. IMPACT: Newborns with congenital heart disease (CHD) born at term gestation demonstrated altered erythropoiesis. Term newborns with CHD have decreased hemoglobin levels despite having red blood cell indices consistent with stress erythropoiesis, suggesting an incomplete compensatory response to in utero physiologic disturbances associated with CHD. The etiology is unknown; however, it may be influenced by multiple risk factors during pregnancy in the maternal-fetal dyad. Alterations in red blood cell indices were not associated with outcomes of fetal growth.
© 2021. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33531673     DOI: 10.1038/s41390-021-01370-4

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  42 in total

1.  Placental insufficiency and fetal growth restriction.

Authors:  Usha Krishna; Sarita Bhalerao
Journal:  J Obstet Gynaecol India       Date:  2011-11-17

2.  Birth weight and cardiovascular malformations: a population-based study. The Baltimore-Washington Infant Study.

Authors:  G L Rosenthal; P D Wilson; T Permutt; J A Boughman; C Ferencz
Journal:  Am J Epidemiol       Date:  1991-06-15       Impact factor: 4.897

3.  Fetal congenital heart disease and intrauterine growth restriction: a retrospective cohort study.

Authors:  Matthew B Wallenstein; Lorie M Harper; Anthony O Odibo; Kimberly A Roehl; Ryan E Longman; George A Macones; Alison G Cahill
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-08

4.  Association between congenital heart defects and small for gestational age.

Authors:  Sadia Malik; Mario A Cleves; Weizhi Zhao; Adolfo Correa; Charlotte A Hobbs
Journal:  Pediatrics       Date:  2007-03-26       Impact factor: 7.124

5.  Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses.

Authors:  K H Nicolaides; D L Economides; P W Soothill
Journal:  Am J Obstet Gynecol       Date:  1989-10       Impact factor: 8.661

6.  Morbidity and mortality after surgery for congenital cardiac disease in the infant born with low weight.

Authors:  Anne M Ades; Troy E Dominguez; Susan C Nicolson; James W Gaynor; Thomas L Spray; Gil Wernovsky; Sarah Tabbutt
Journal:  Cardiol Young       Date:  2009-12-18       Impact factor: 1.093

7.  Fetal somatic growth trajectory differs by type of congenital heart disease.

Authors:  Kriti Puri; Carri R Warshak; Mounira A Habli; Amy Yuan; Rashmi D Sahay; Eileen C King; Allison Divanovic; James F Cnota
Journal:  Pediatr Res       Date:  2017-12-20       Impact factor: 3.756

8.  Patterns of prenatal growth among infants with cardiovascular malformations: possible fetal hemodynamic effects.

Authors:  G L Rosenthal
Journal:  Am J Epidemiol       Date:  1996-03-01       Impact factor: 4.897

9.  Survival, by Birth Weight and Gestational Age, in Individuals With Congenital Heart Disease: A Population-Based Study.

Authors:  Kate E Best; Peter W G Tennant; Judith Rankin
Journal:  J Am Heart Assoc       Date:  2017-07-21       Impact factor: 5.501

10.  Characterization of the Placenta in the Newborn with Congenital Heart Disease: Distinctions Based on Type of Cardiac Malformation.

Authors:  Jack Rychik; Donna Goff; Eileen McKay; Antonio Mott; Zhiyun Tian; Daniel J Licht; J William Gaynor
Journal:  Pediatr Cardiol       Date:  2018-05-04       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.